BioMarin announces governance enhancements and value creation initiatives
Client(s) Board of Directors of BioMarin Pharmaceutical Inc.
Jones Day advised the Board of Directors of BioMarin Pharmaceutical Inc. ("BioMarin") in connection with its entry into a Cooperation Agreement and an Information Sharing Agreement with activist shareholder Elliott Management. Under the Cooperation Agreement, the Board approved the appointment of three new independent directors and established a new Strategic and Operating Review Committee. Elliott agreed to customary standstill, voting, confidentiality, and other provisions.